Robert A. Schwartzman

Array ( [id] => 4181987 [patent_doc_number] => 06159729 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-12 [patent_title] => 'Synthetic HPV6/11 hybrid L1 DNA encoding human papillomavirus type 11 L1 protein' [patent_app_type] => 1 [patent_app_number] => 8/913462 [patent_app_country] => US [patent_app_date] => 1998-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14214 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/159/06159729.pdf [firstpage_image] =>[orig_patent_app_number] => 913462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4158663 [patent_doc_number] => 06103872 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-15 [patent_title] => 'CAPON: a protein associated with neuronal nitric oxide synthase' [patent_app_type] => 1 [patent_app_number] => 9/010998 [patent_app_country] => US [patent_app_date] => 1998-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 17 [patent_no_of_words] => 17846 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/103/06103872.pdf [firstpage_image] =>[orig_patent_app_number] => 010998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4304334 [patent_doc_number] => 06187757 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Regulation of biological events using novel compounds' [patent_app_type] => 1 [patent_app_number] => 9/012097 [patent_app_country] => US [patent_app_date] => 1998-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 51233 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187757.pdf [firstpage_image] =>[orig_patent_app_number] => 012097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3949440 [patent_doc_number] => 05998600 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => '.beta.-catenin, TCF-4, and APC interact to prevent cancer' [patent_app_type] => 1 [patent_app_number] => 9/003687 [patent_app_country] => US [patent_app_date] => 1998-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 16 [patent_no_of_words] => 14272 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/998/05998600.pdf [firstpage_image] =>[orig_patent_app_number] => 003687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4418879 [patent_doc_number] => 06177261 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-23 [patent_title] => 'Method to isolate mutants and to clone the complementing gene' [patent_app_type] => 1 [patent_app_number] => 8/981729 [patent_app_country] => US [patent_app_date] => 1997-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 22228 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/177/06177261.pdf [firstpage_image] =>[orig_patent_app_number] => 981729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4404405 [patent_doc_number] => 06228371 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-08 [patent_title] => 'Mycobacterium tuberculosis DNA sequences encoding immunostimulatory peptides' [patent_app_type] => 1 [patent_app_number] => 8/990823 [patent_app_country] => US [patent_app_date] => 1997-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14112 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/228/06228371.pdf [firstpage_image] =>[orig_patent_app_number] => 990823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4084563 [patent_doc_number] => 06017731 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-25 [patent_title] => 'Method for expression of heterologous proteins in yeast' [patent_app_type] => 1 [patent_app_number] => 8/989251 [patent_app_country] => US [patent_app_date] => 1997-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20849 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/017/06017731.pdf [firstpage_image] =>[orig_patent_app_number] => 989251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4100963 [patent_doc_number] => 06051381 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-18 [patent_title] => 'Prokaryotic two-hybrid system' [patent_app_type] => 1 [patent_app_number] => 8/987965 [patent_app_country] => US [patent_app_date] => 1997-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 10216 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/051/06051381.pdf [firstpage_image] =>[orig_patent_app_number] => 987965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4186823 [patent_doc_number] => 06153383 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-28 [patent_title] => 'Synthetic transcriptional modulators and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/987912 [patent_app_country] => US [patent_app_date] => 1997-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 25595 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/153/06153383.pdf [firstpage_image] =>[orig_patent_app_number] => 987912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3976581 [patent_doc_number] => 05905025 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-18 [patent_title] => 'Chimeric proteins activating polymerase III transcription, use thereof for detecting and analysing protein-protein interactions and genes coding for said proteins' [patent_app_type] => 1 [patent_app_number] => 8/952504 [patent_app_country] => US [patent_app_date] => 1997-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5216 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/905/05905025.pdf [firstpage_image] =>[orig_patent_app_number] => 952504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4049891 [patent_doc_number] => 05932423 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-03 [patent_title] => 'Cyclic nucleotide phosphodiesterases' [patent_app_type] => 1 [patent_app_number] => 8/974565 [patent_app_country] => US [patent_app_date] => 1997-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 24987 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/932/05932423.pdf [firstpage_image] =>[orig_patent_app_number] => 974565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3998901 [patent_doc_number] => 05986055 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'CDK2 interactions' [patent_app_type] => 1 [patent_app_number] => 8/969106 [patent_app_country] => US [patent_app_date] => 1997-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 9 [patent_no_of_words] => 46291 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/986/05986055.pdf [firstpage_image] =>[orig_patent_app_number] => 969106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4079573 [patent_doc_number] => 06054273 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-25 [patent_title] => 'Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents' [patent_app_type] => 1 [patent_app_number] => 8/967454 [patent_app_country] => US [patent_app_date] => 1997-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10205 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/054/06054273.pdf [firstpage_image] =>[orig_patent_app_number] => 967454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3939142 [patent_doc_number] => 05989805 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Immortal avian cell line to grow avian and animal viruses to produce vaccines' [patent_app_type] => 1 [patent_app_number] => 8/967716 [patent_app_country] => US [patent_app_date] => 1997-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 17352 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/989/05989805.pdf [firstpage_image] =>[orig_patent_app_number] => 967716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4138001 [patent_doc_number] => 06060275 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'Sprouty protein and coding sequence' [patent_app_type] => 1 [patent_app_number] => 8/965903 [patent_app_country] => US [patent_app_date] => 1997-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 74 [patent_no_of_words] => 23296 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060275.pdf [firstpage_image] =>[orig_patent_app_number] => 965903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4013616 [patent_doc_number] => 05962667 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Pharmaco-gene delivery in human breast cancer cells' [patent_app_type] => 1 [patent_app_number] => 8/962613 [patent_app_country] => US [patent_app_date] => 1997-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 4692 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962667.pdf [firstpage_image] =>[orig_patent_app_number] => 962613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4071419 [patent_doc_number] => 05965368 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'Reverse two-hybrid systems' [patent_app_type] => 1 [patent_app_number] => 8/959536 [patent_app_country] => US [patent_app_date] => 1997-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 28 [patent_no_of_words] => 23888 [patent_no_of_claims] => 105 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965368.pdf [firstpage_image] =>[orig_patent_app_number] => 959536 [rel_patent_id] =>[rel_patent_doc_number] =>)